אטורבה טבע  80 מג ישראל - עברית - Ministry of Health

אטורבה טבע 80 מג

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - טבליה - atorvastatin as calcium 80 mg - atorvastatin

אטורבה טבע  80 מג ישראל - עברית - Ministry of Health

אטורבה טבע 80 מג

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - טבליה - atorvastatin as calcium 80 mg - atorvastatin

ליפיטור 40 מג ישראל - עברית - Ministry of Health

ליפיטור 40 מג

pfizer pfe pharmaceuticals israel ltd - atorvastatin as calcium - טבליה - atorvastatin as calcium 40 mg - atorvastatin

טורבה 80 ישראל - עברית - Ministry of Health

טורבה 80

unipharm ltd, israel - atorvastatin as calcium trihydrate - טבליות מצופות - atorvastatin as calcium trihydrate 80 mg - atorvastatin

אזאטור אס.קיי. 1010 מג ישראל - עברית - Ministry of Health

אזאטור אס.קיי. 1010 מג

k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - ezetimibe 10 mg; atorvastatin as calcium trihydrate 10 mg - atorvastatin and ezetimibe

אזאטור אס.קיי. 2010 מג ישראל - עברית - Ministry of Health

אזאטור אס.קיי. 2010 מג

k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - ezetimibe 10 mg; atorvastatin as calcium trihydrate 20 mg - atorvastatin and ezetimibe

אזאטור אס.קיי. 4010 מג ישראל - עברית - Ministry of Health

אזאטור אס.קיי. 4010 מג

k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - ezetimibe 10 mg; atorvastatin as calcium trihydrate 40 mg - atorvastatin and ezetimibe

אזאטור אס.קיי. 8010 מג ישראל - עברית - Ministry of Health

אזאטור אס.קיי. 8010 מג

k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - ezetimibe 10 mg; atorvastatin as calcium trihydrate 80 mg - atorvastatin and ezetimibe

אטורבסטאטין טבע ® 10 מ"ג ישראל - עברית - Ministry of Health

אטורבסטאטין טבע ® 10 מ"ג

teva pharmaceutical indust.ltd - atorvastatin as calcium 10 mg - tablets - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl

אטורבסטאטין טבע ® 20 מ"ג ישראל - עברית - Ministry of Health

אטורבסטאטין טבע ® 20 מ"ג

teva pharmaceutical indust.ltd - atorvastatin as calcium 20 mg - tablets - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl